GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » Debt-to-Equity

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Debt-to-Equity : 0.00 (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk Debt-to-Equity?

PT Diagnos Laboratorium Utama Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. PT Diagnos Laboratorium Utama Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. PT Diagnos Laboratorium Utama Tbk's Total Stockholders Equity for the quarter that ended in . 20 was Rp0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity or its related term are showing as below:

ISX:DGNS's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.23
* Ranked among companies with meaningful Debt-to-Equity only.

PT Diagnos Laboratorium Utama Tbk Debt-to-Equity Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk Debt-to-Equity Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
Debt-to-Equity

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
Debt-to-Equity

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity falls into.



PT Diagnos Laboratorium Utama Tbk Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PT Diagnos Laboratorium Utama Tbk's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

PT Diagnos Laboratorium Utama Tbk's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


PT Diagnos Laboratorium Utama Tbk Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Main Laboratory Diagnos Tbk provides laboratory services that includes health support service activities that are managed by both the government and the private sector, such as health laboratories. The company's products and services include Service Home Service, Corporate Service, Clinical Laboratory, Genomics Laboratory, Inspection Package, Homecare Diagnos, and Examination Panel.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Headlines

From GuruFocus

Cvent Announces New Independent Board Members for Post-Merger Company

By Business Wire Business Wire 12-01-2021

Cvent CEO & Founder to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-12-2021

Cvent and Dragoneer to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-29-2021